Skin test skip for Kids' antibiotic allergies shows promise

NCT ID NCT03553251

Completed Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether children under 16 with a history of mild beta-lactam (like penicillin) allergies could safely take the drug again without first having skin tests. Researchers used a questionnaire to identify low-risk kids and then gave them an oral dose. The goal was to see if this approach kept severe allergic reactions below 2%. The study involved 195 children and aimed to simplify allergy care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: beta-lactam antibiotics (e.g., penicillin)
What this could lead to: If successful, this could lead to simpler, faster allergy testing for children, avoiding unnecessary skin tests and allowing safe use of common antibiotics.
What could go wrong: This is a small, completed study with 195 children, so results may not apply to all kids. There is still a small risk of allergic reaction, and the approach only works for those already deemed low-risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BETA LACTAM ADVERSE REACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic disease drug allergy hypersensitivity reaction disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BETA LACTAM ADVERSE REACTION HYPERSENSITIVITY

Contacts and locations

Locations

Nantes University Hospital

Nantes, Loire-Atlantique, 44093, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.